unknown
Stage
About
BreakSight provides technology for capturing and sequencing DNA double-strand break sites across the genome, enabling genomic analysis for cancer research, drug development, and biomarker discovery.
Explore BreakSight's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.